Your Source for Venture Capital and Private Equity Financings

Vedanta Biosciences Completes $68M Series D

2021-07-21
CAMBRIDGE, MA, Vedanta Biosciences, a clinical-stage microbiome company, has raised a $68M Series D financing led by affiliates of Magnetar Capital.
Vedanta Biosciences, a clinical-stage microbiome company, has raised a Series D financing led by affiliates of Magnetar Capital.

Other participants in the financing were new and existing investors including Verition Fund Management, Fosun Health Capital, co-founder PureTech Health, Rock Springs Capital, Skyviews Life Science, JSR Corporation, SymBiosis LLC, Shumway Capital, Health for Life Capital (Seventure Partners), and other institutional investors. The round also includes a $25 million investment from Pfizer.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors